-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$8.00323.28% Upside
Cardiol Therapeutics Inc. Frequently Asked Questions
-
What analysts cover Cardiol Therapeutics Inc.?
Cardiol Therapeutics Inc. has been rated by research analysts at Canaccord Genuity in the past 90 days.